Loading...

ARF-BP1 as a potential therapeutic target

In this review, we discuss the recent identification of ARF-BP1 (also known as Mule, UREB1, E3(histone), LASU1, and HectH9). ARF-BP1, a HECT domain-containing E3 ubiquitin ligase, interacts with ARF and p53. Its ubiquitin ligase activity is inhibited by ARF. Inactivation of ARF-BP1 stabilised p53 an...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen, D, Brooks, C L, Gu, W
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2006
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361317/
https://ncbi.nlm.nih.gov/pubmed/16641901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603119
Tags: Add Tag
No Tags, Be the first to tag this record!